Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
May 20 2009 - 9:27AM
PR Newswire (US)
NEW YORK, May 20 /PRNewswire/ -- Carl C. Icahn announced today that
three influential independent proxy voting advisory services,
RiskMetrics Group, Glass Lewis & Co and PROXY Governance, Inc.,
have recommended that stockholders of Amylin Pharmaceuticals, Inc.
(NASDAQ:AMLN) support stockholder nominees for election to the
Board of Directors of Amylin's at the 2009 Annual Meeting of
Stockholders. -- RiskMetrics Group has recommended that Amylin
stockholders vote FOR the election of our nominee, Dr. Alexander J.
Denner and FOR the election of Eastbourne nominees, Dr. Kathleen
Behrens and Charles Fleischman. -- Glass Lewis & Co has
recommended that Amylin stockholders vote FOR the election of our
nominee Dr. Alexander J. Denner and Eastbourne nominees, Dr.
Kathleen Behrens and Jay Sherwood. -- PROXY Governance, Inc. has
recommended Amylin stockholders vote FOR the election of our
nominees, Dr. Alexander J. Denner and Dr. Thomas Deuel and
Eastbourne nominees, Dr. Kathleen Behrens, Charles Fleischman and
Jay Sherwood. In order to follow any of the above recommendations,
which were made by three leading independent proxy voting advisory
services, stockholders CANNOT use the blue proxy card since the
names of the nominees of Icahn and Eastbourne cannot be written in.
To reiterate, stockholders should NOT vote the blue proxy card
because the blue proxy card will NOT allow stockholders, among
other things, to vote for either of our nominees (Dr. Alexander J.
Denner and Dr. Thomas Deuel). We urge stockholders to use our GOLD
proxy card to elect Dr. Alexander J. Denner and Dr. Thomas Deuel.
The GOLD proxy card will allow stockholders to vote for Dr.
Alexander J. Denner and Dr. Thomas Deuel and will have the effect
of voting for the Eastbourne nominees as well as the seven
management nominees described thereon. If you wish to withhold
authority for any of our nominees or any of the nominees of
Eastbourne or any of the seven management nominees you may mark the
"for all except" box and write the name of the nominees you do not
support. Stockholders are reminded that they CANNOT vote the blue
proxy card to vote for any of our nominees or any of the nominees
of Eastbourne and are urged to support our nominees on our GOLD
proxy card. If you have any questions about voting your shares,
please call Edward McCarthy or Richard Grubaugh of D.F. King &
Co., Inc at (212) 269-5550. ON MAY 6, 2009, THE PARTICIPANTS FILED
A DEFINITIVE PROXY STATEMENT WITH THE SECURITIES AND EXCHANGE
COMMISSION. SECURITY HOLDERS ARE ADVISED TO READ THE DEFINITIVE
PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF
PROXIES BY CARL C. ICAHN, DR. ALEXANDER J. DENNER, DR. THOMAS F.
DEUEL, MAYU SRIS, JEFFREY MECKLER, DR. ERIC ENDE, ICAHN PARTNERS
LP, ICAHN PARTNERS MASTER FUND LP, ICAHN PARTNERS MASTER FUND II
LP, ICAHN PARTNERS MASTER FUND III LP, ICAHN ENTERPRISES G.P. INC.,
ICAHN ENTERPRISES HOLDINGS L.P., IPH GP LLC, ICAHN CAPITAL L.P.,
ICAHN ONSHORE LP, ICAHN OFFSHORE LP, BECKTON CORP., AND CERTAIN OF
THEIR RESPECTIVE AFFILIATES FROM THE STOCKHOLDERS OF AMYLIN
PHARMACEUTICALS, INC. FOR USE AT ITS ANNUAL MEETING, BECAUSE THEY
CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO
THE PARTICIPANTS. THE DEFINITIVE PROXY STATEMENT AND A FORM OF
PROXY IS AVAILABLE TO STOCKHOLDERS OF AMYLIN PHARMACEUTICALS INC.
FROM THE PARTICIPANTS AT NO CHARGE AND IS ALSO AVAILABLE AT NO
CHARGE AT THE SECURITIES AND EXCHANGE COMMISSION'S WEBSITE AT
http://www.sec.gov/ OR BY CONTACTING D.F. KING & CO., INC. BY
TELEPHONE TOLL FREE AT 1-800-488-8075. DATASOURCE: Carl C. Icahn
CONTACT: Susan Gordon, +1-212-702-4309
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024